Five Biotechs Announce New-Hire Equity Grants
Several biotechnology and pharmaceutical companies announced equity awards for newly hired employees under Nasdaq Listing Rule 5635(c)(4). InspireMD approved 18,000 restricted shares for one employee, vesting over three years, while Precision BioSciences granted 39,146 restricted stock units among five employees, also vesting in annual installments over three years. Azora Therapeutics granted one new employee an option for 40,000 shares, vesting over four years, and Elutia awarded two new employees a total of 378,000 stock options, with vesting spread across four years. Arrowhead Pharmaceuticals also reported inducement grants under the Nasdaq rule, though the provided report does not specify their size or terms. These awards are intended to attract new employees and are generally contingent on continued employment or service.
How it spread





